AZD9150 (ISIS-STAT3Rx)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD9150 (ISIS-STAT3Rx), covering 2017-03-06 to 2017-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma [Phase 1]